I'm not caring about the options, to be honest, i don't dabble in those.
Michael states "The Company is poised for significant growth following the completion of its Phase 2 Studyfor the treatment of B-Cell Lymphoma in dogs and after recently successfully completing dosing in itsPhase 1 MEND Study of monepantel in patients with motor neurone disease".
He seems like a good egg, so I'll give him the benefit of the doubt and remain hopeful!
V.
Ann: Options Offer to Existing Listed Option Holders, page-5
-
- There are more pages in this discussion • 75 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
-0.005(2.94%) |
Mkt cap ! $80.25M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.0¢ | 16.5¢ | $70.28K | 418.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 217323 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 43978 | 1 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |